a company which engages in the identification and development of oncology therapeutics
Industry Biotechnology
A.I.dvisor tells us that TRAW and AVTE have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRAW and AVTE's prices will move in lockstep.
Ticker / NAME | Correlation To TRAW | 1D Price Change % | ||
---|---|---|---|---|
TRAW | 100% | -1.21% | ||
AVTE - TRAW | 25% Poorly correlated | -3.63% | ||
PRTA - TRAW | 25% Poorly correlated | -4.63% | ||
MDXG - TRAW | 23% Poorly correlated | -6.73% | ||
INKT - TRAW | 23% Poorly correlated | +1.22% | ||
PCVX - TRAW | 22% Poorly correlated | +36.39% | ||
More |